Additionally, the report provides an overview of key players involved in therapeutic development for Neurofibromatoses and features dormant and discontinued projects.
The report provides a snapshot of the global therapeutic landscape of Neurofibromatoses
A snapshot of the global therapeutic scenario for Neurofibromatoses.
A review of the Neurofibromatoses products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Global Markets Direct's, 'Neurofibromatoses
Type II - Pipeline Review, H1 2016', provides an overview of the Neurofibromatoses
Type II pipeline landscape.
This report provides information on the therapeutic development for Neurofibromatoses
Type II, complete with latest updates, and special features on late-stage and discontinued projects.